Explaining why increases in generic use outpace decreases in brand name medicine use in multisource markets and the role of regulation

Healthcare systems worldwide face escalating pharmaceutical expenditures despite interventions targeting pricing and generic substitution. Existing studies often overlook unwarranted volume increases in multisource markets due to differential physician perceptions of brand name and generics.